To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
All the news of the Institute of life sciences Frédéric Joliot
Laboratory | Mass spectrometry
Small Molecules Analysis by Mass Spectrometry
is a platform dedicated to the absolute quantification of small molecules,
drugs, metabolites and biomarkers in biological fluids.
LeaderAlain PRUVOST33 1 69 08 13 firstname.lastname@example.org
Permanent staffAurélie Ghettas-Messager, TechnicianFrédéric Théodoro, Technician
This platform is implanted in the Pharmacology and Immunoanalysis unit (SPI); it comprises 5 liquid chromatography instruments together with mass spectrometers triple quadrupole analyzers (UPLC-MS/MS). SMArt-MS can access if needed to the high-resolution instruments of MetaboHUB platform. Human resources of the platform are composed of a CEA engineer, two CEA technicians and non-statutory personnel.
Our missions are:
SMArt-MS performs these activities for the Laboratory of Drug Metabolism Research (SPI), other CEA laboratories, LabEx LERMIT which SPI is part and external partners.
SMArt-MS present partners:
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.